As of 2025-03-15, the Relative Valuation of Acerus Pharmaceuticals Corporation (ASP.TO) is (162.47) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.36 CAD, the upside of Acerus Pharmaceuticals Corporation based on Relative Valuation is -45230.7%.
The range of the Relative Valuation is (153.96) - (158.99) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 29.4x - 44.1x | 36.8x |
| Forward P/E multiples | 20.2x - 30.4x | 25.3x |
| Fair Price | (153.96) - (158.99) | (162.47) |
| Upside | -42866.9% - -44263.4% | -45230.7% |
| Date | P/E |